Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 776 to 800 of 2535

TitleReference numberPublishedLast updated
Nivolumab for adjuvant treatment of resected oesophageal or gastro-oesophageal junction cancerTA746
Upadacitinib for treating moderate rheumatoid arthritisTA744
NBTXR-3 for treating advanced soft tissue sarcoma (terminated appraisal)TA745
Inducing labourNG207
Inducing labourQS60
24/7 EEG SubQ for epilepsyMIB277
Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and managementNG206
Apalutamide with androgen deprivation therapy for treating high-risk hormone-relapsed non-metastatic prostate cancerTA740
Apalutamide with androgen deprivation therapy for treating hormone-sensitive metastatic prostate cancerTA741
Atezolizumab for untreated PD-L1-positive advanced urothelial cancer when cisplatin is unsuitableTA739
Genicular artery embolisation for pain from knee osteoarthritisHTG595
Laparoscopic renal denervation for loin pain haematuria syndromeHTG596
Percutaneous endovascular forearm arteriovenous fistula creation for haemodialysis accessHTG597
Looked-after children and young peopleNG205
Tofacitinib for treating juvenile idiopathic arthritisTA735
Nivolumab for treating recurrent or metastatic squamous cell carcinoma of the head and neck after platinum-based chemotherapyTA736
Berotralstat for preventing recurrent attacks of hereditary angioedemaTA738
Secukinumab for treating moderate to severe plaque psoriasis in children and young peopleTA734
Baloxavir marboxil for treating acute uncomplicated influenza (terminated appraisal)TA732
Inclisiran for treating primary hypercholesterolaemia or mixed dyslipidaemiaTA733
DyeVert Systems for reducing the risk of acute kidney injury in coronary and peripheral angiographyHTG594
Avapritinib for treating unresectable or metastatic gastrointestinal stromal tumours (terminated appraisal)TA730
Vericiguat for treating chronic heart failure with reduced ejection fraction (terminated appraisal)TA731
Daratumumab with pomalidomide and dexamethasone for treating relapsed or refractory multiple myeloma (terminated appraisal)TA726
Isatuximab with carfilzomib and dexamethasone for treating relapsed or refractory multiple myeloma (terminated appraisal)TA727

Results per page

  1. 10
  2. 25
  3. 50
  4. All